On October 30, 2019 Cellular Biomedicine Group Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerative diseases, reported that it will release its financial results for the third quarter ended September 30, 2019 after the market closes on Wednesday, November 6, 2019 (Press release, Cellular Biomedicine Group, OCT 30, 2019, View Source [SID1234550079]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
The Company will host a conference call and webcast with the investment community on Wednesday, November 6th at 4:30 p.m. Eastern Time featuring remarks by Tony Liu, Executive Director, CEO and CFO of CBMG.
What:
Cellular Biomedicine Third Quarter 2019 Results Conference Call
Date:
Wednesday, November 6, 2019
Time:
4:30 p.m. Eastern Time
Live Call:
Toll-Free: 1-855-327-6837
International: 1-631-891-4304
Webcast:
Replay:
Toll-Free: 1-844-512-2921
International: 1-412-317-6671
Conference ID: 10007976
(Available approximately two hours after the completion of the live call until 11:59 p.m. ET on November 20, 2019)